Charles Piller, author of the new book Doctored, says the scientific community needs “to take a good hard look in the mirror.

The finding may open a whole new world in the study of Alzheimer's disease, said biophysicist Aneta Stefanovska.

In a bid to revolutionize Alzheimer’s detection, scientists have examined the brain’s neurovascular unit. The research ...

COVID-19, even in mild cases, is linked to changes in Alzheimer’s disease-related brain biomarkers comparable to four years ...

For years, scientists have focused on amyloid beta buildup as the main culprit in Alzheimer’s disease, but a new study suggests the real problem might lie in a stalled protein-cutting process in the ...

According to recent research published in ‘Alzheimer's & Dementia’, delays in entering the rapid eye movement (REM) sleep phase may signal early signs of Alzheimer's disease. The study found that ...

Insights into the structures could lead to improved treatment strategies for transthyretin amyloidosis, a progressive, fatal disease in men.

Researchers have uncovered a link between COVID-19 and blood markers linked to faulty proteins in the brain. The analysis, ...

The tiny protein known as transthyretin can cause big problems in the body when it misfolds after secretion. While healthy ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access information on a device and to provide personalised ads and content, ad and ...

Now, Scripps Research scientists have uncovered new structures of transthyretin. Their findings, published in Nature Structural & Molecular Biology on January 22, 2025, show how the three-dimension ...

Local amyloid deposition occurs in the brain in Alzheimer's disease and in the pancreas in maturity-onset diabetes, but a direct role in the pathogenesis of these diseases remains unproven.